| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Y7506 |
|
6,601 |
5,913 |
$6.65M |
| Y7507 |
|
5,760 |
5,096 |
$5.45M |
| X4011 |
State-specific procedure code |
19,037 |
17,359 |
$3.58M |
| 94760 |
|
2,245 |
2,078 |
$3.16M |
| D7999 |
|
1,259 |
1,241 |
$3.13M |
| X4006 |
|
890 |
709 |
$1.63M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,144 |
9,388 |
$1.55M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,553 |
6,924 |
$1.50M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,090 |
25,262 |
$1.17M |
| 80053 |
Comprehensive metabolic panel |
30,811 |
25,227 |
$1.08M |
| 81001 |
|
10,900 |
10,046 |
$797K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,298 |
2,093 |
$607K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,547 |
6,687 |
$464K |
| 36415 |
Collection of venous blood by venipuncture |
25,166 |
19,263 |
$313K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,123 |
2,787 |
$263K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,577 |
1,492 |
$255K |
| 87581 |
|
2,167 |
2,063 |
$254K |
| 87486 |
|
2,148 |
2,045 |
$253K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
783 |
756 |
$186K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
660 |
624 |
$186K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
847 |
776 |
$179K |
| G0378 |
Hospital observation service, per hour |
214 |
193 |
$138K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,047 |
989 |
$129K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,115 |
1,032 |
$125K |
| X4003 |
|
848 |
423 |
$114K |
| 82550 |
|
3,127 |
2,683 |
$113K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
988 |
559 |
$107K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
330 |
126 |
$95K |
| 71046 |
Radiologic examination, chest; 2 views |
511 |
468 |
$94K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
223 |
75 |
$84K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
22,083 |
18,357 |
$76K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
786 |
718 |
$71K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,327 |
1,118 |
$68K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,730 |
3,387 |
$64K |
| 36591 |
|
2,914 |
1,559 |
$62K |
| 71045 |
Radiologic examination, chest; single view |
1,640 |
1,498 |
$59K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,095 |
1,369 |
$54K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
164 |
133 |
$44K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
502 |
311 |
$41K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
447 |
393 |
$38K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
117 |
101 |
$34K |
| 59025 |
Fetal non-stress test |
80 |
52 |
$30K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
347 |
298 |
$26K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
748 |
420 |
$25K |
| J3490 |
Unclassified drugs |
1,749 |
919 |
$24K |
| 83735 |
|
243 |
213 |
$22K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
252 |
153 |
$20K |
| 84439 |
|
231 |
207 |
$17K |
| 82553 |
|
462 |
386 |
$17K |
| 84484 |
|
589 |
478 |
$17K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
129 |
128 |
$16K |
| 83690 |
|
234 |
211 |
$15K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
16 |
14 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
841 |
758 |
$12K |
| 86850 |
|
27 |
24 |
$12K |
| 81025 |
|
156 |
145 |
$11K |
| 80061 |
Lipid panel |
948 |
888 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
275 |
256 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
275 |
256 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
741 |
639 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
277 |
251 |
$10K |
| 87510 |
|
27 |
24 |
$7K |
| 87480 |
|
27 |
24 |
$7K |
| 87660 |
|
27 |
24 |
$7K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
77 |
77 |
$7K |
| 80050 |
General health panel |
19 |
19 |
$6K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
12 |
$6K |
| 86141 |
|
74 |
64 |
$5K |
| 84702 |
|
191 |
151 |
$5K |
| 0100U |
|
19 |
19 |
$5K |
| 93017 |
|
13 |
12 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
116 |
115 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
390 |
355 |
$3K |
| 82728 |
|
426 |
334 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
216 |
47 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
52 |
46 |
$3K |
| 87081 |
|
307 |
295 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
86 |
83 |
$2K |
| 88342 |
|
35 |
26 |
$2K |
| 85027 |
|
209 |
184 |
$2K |
| D9420 |
|
197 |
186 |
$2K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
84 |
55 |
$2K |
| 83550 |
|
389 |
304 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
208 |
199 |
$1K |
| 86592 |
|
15 |
12 |
$1K |
| 70450 |
Computed tomography, head or brain; without contrast material |
25 |
25 |
$1K |
| 86140 |
|
433 |
408 |
$1K |
| 86235 |
|
12 |
12 |
$1K |
| 88142 |
|
69 |
67 |
$1K |
| 87906 |
|
15 |
13 |
$1K |
| 83540 |
|
388 |
303 |
$1K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
13 |
13 |
$835.95 |
| 83615 |
|
230 |
169 |
$813.17 |
| 87536 |
|
15 |
13 |
$637.73 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
34 |
14 |
$605.50 |
| 82607 |
|
47 |
44 |
$547.93 |
| 82950 |
|
13 |
13 |
$529.24 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
198 |
183 |
$525.00 |
| 99221 |
|
20 |
12 |
$421.66 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
23 |
12 |
$395.33 |
| 84145 |
|
25 |
24 |
$338.84 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
93 |
80 |
$337.83 |
| 86360 |
|
14 |
12 |
$325.50 |
| 85652 |
|
158 |
156 |
$313.44 |
| 96367 |
|
17 |
12 |
$258.54 |
| 84436 |
|
12 |
12 |
$254.44 |
| 80143 |
|
17 |
16 |
$240.30 |
| 80179 |
|
17 |
16 |
$240.30 |
| 85610 |
|
61 |
55 |
$213.45 |
| 86803 |
|
13 |
13 |
$181.70 |
| 86756 |
|
13 |
12 |
$146.78 |
| 84703 |
|
38 |
36 |
$128.57 |
| 86225 |
|
12 |
12 |
$127.93 |
| 81003 |
|
12 |
12 |
$20.39 |
| J2704 |
Injection, propofol, 10 mg |
313 |
291 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
14 |
13 |
$0.00 |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
13 |
12 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
225 |
215 |
$0.00 |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
13 |
12 |
$0.00 |
| D1120 |
Prophylaxis - child |
14 |
13 |
$0.00 |